Zhanghai He

809 total citations
18 papers, 611 citations indexed

About

Zhanghai He is a scholar working on Cancer Research, Molecular Biology and Surgery. According to data from OpenAlex, Zhanghai He has authored 18 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 9 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Zhanghai He's work include MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Zhanghai He is often cited by papers focused on MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Zhanghai He collaborates with scholars based in China and India. Zhanghai He's co-authors include Duoguang Wu, Minghui Wang, Huayue Lin, Wenjian Wang, Xiaotian He, Jiatong Lin, Xueting Hu, Zihao Pan, Kefeng Wang and Huiying Zhao and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Sports Medicine and British Journal of Cancer.

In The Last Decade

Zhanghai He

17 papers receiving 606 citations

Peers

Zhanghai He
Zhanghai He
Citations per year, relative to Zhanghai He Zhanghai He (= 1×) peers Jia‐Bo Zheng

Countries citing papers authored by Zhanghai He

Since Specialization
Citations

This map shows the geographic impact of Zhanghai He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhanghai He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhanghai He more than expected).

Fields of papers citing papers by Zhanghai He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhanghai He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhanghai He. The network helps show where Zhanghai He may publish in the future.

Co-authorship network of co-authors of Zhanghai He

This figure shows the co-authorship network connecting the top 25 collaborators of Zhanghai He. A scholar is included among the top collaborators of Zhanghai He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhanghai He. Zhanghai He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhang, Wei, et al.. (2025). RNA methylation of CD47 mediates tumor immunosuppression in EGFR-TKI resistant NSCLC. British Journal of Cancer. 132(6). 569–579. 2 indexed citations
2.
Huang, Guowei, Zhanghai He, Jiewen Chen, et al.. (2024). LncRNA ZFPM2-AS1 promotes phyllodes tumor progression by binding to CDC42 and inhibiting STAT1 activation. Acta Pharmaceutica Sinica B. 14(7). 2942–2958. 1 indexed citations
3.
Tian, Zhenluan, et al.. (2023). Effect of 1H‐NMR serum lipoproteins on immunotherapy response in advanced triple‐negative breast cancer patients. Cancer Science. 114(10). 3924–3934. 3 indexed citations
5.
Guo, Jiang, Zhanghai He, Weike Zeng, et al.. (2022). H-loop Knotless Double-Row Repair Versus Knotted Suture Bridge for Rotator Cuff Tears: A Biomechanical and Histological Study in an Animal Model. The American Journal of Sports Medicine. 50(7). 1948–1959. 4 indexed citations
7.
Liu, Yuxiang, et al.. (2021). Clinicopathological characteristics of IgG4-related lung disease. BMC Pulmonary Medicine. 21(1). 413–413. 6 indexed citations
9.
He, Zhanghai, et al.. (2020). Overexpression of gasdermin D promotes invasion of adenoid cystic carcinoma.. PubMed Central. 13(7). 1802–1811. 11 indexed citations
10.
Chao, Xue, Xiaoyan Jin, Cui Tan, et al.. (2020). Re-excision or “wait and watch”—a prediction model in breast phyllodes tumors after surgery. Annals of Translational Medicine. 8(6). 371–371. 16 indexed citations
11.
Zhou, Qiming, Qinghua Liu, Zhanghai He, et al.. (2020). PRL-3 facilitates Hepatocellular Carcinoma progression by co-amplifying with and activating FAK. Theranostics. 10(22). 10345–10359. 16 indexed citations
12.
He, Zhanghai, et al.. (2020). Drug-induced Interstitial Lung Disease in Breast Cancer Patients: A Lesson We Should Learn From Multi-Disciplinary Integration. SHILAP Revista de lepidopterología. 1(2). 8 indexed citations
13.
Hu, Xueting, Duoguang Wu, Xiaotian He, et al.. (2019). circGSK3β promotes metastasis in esophageal squamous cell carcinoma by augmenting β-catenin signaling. Molecular Cancer. 18(1). 160–160. 139 indexed citations
14.
Wang, Wenjian, Duoguang Wu, Xiaotian He, et al.. (2019). CCL18-induced HOTAIR upregulation promotes malignant progression in esophageal squamous cell carcinoma through the miR-130a-5p-ZEB1 axis. Cancer Letters. 460. 18–28. 49 indexed citations
15.
Hu, Xueting, Jiatong Lin, Ming Jiang, et al.. (2019). HIF-1α Promotes the Metastasis of Esophageal Squamous Cell Carcinoma by Targeting SP1. Journal of Cancer. 11(1). 229–240. 25 indexed citations
16.
Yang, Yaping, Ying Wang, Heran Deng, et al.. (2019). Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer. BMC Cancer. 19(1). 541–541. 24 indexed citations
17.
Dai, Lei, Lei Wang, Wenjian Wang, et al.. (2019). Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer. The Oncologist. 24(11). e1070–e1081. 89 indexed citations
18.
Fu, Zhiqiang, Changhao Chen, Quanbo Zhou, et al.. (2017). LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9. Cancer Letters. 410. 68–81. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026